Andrew Makin Preclinical Consulting ApS

Andrew Makin Preclinical Consulting ApS (CVR number: 40625240) is a company from FREDENSBORG. The company recorded a gross profit of 1352.8 kDKK in 2023. The operating profit was 580.7 kDKK, while net earnings were 449 kDKK. The profitability of the company measured by Return on Assets (ROA) was 54.1 %, which can be considered excellent and Return on Equity (ROE) was 66.1 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 60.4 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. Andrew Makin Preclinical Consulting ApS's liquidity measured by quick ratio was 2.5 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.